Literature DB >> 28701509

Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function.

Laurent Gorvel1, Daniel Korenfeld1, Thomas Tung2, Eynav Klechevsky3.   

Abstract

Cytokines produced by dendritic cells (DCs) can largely determine the direction of immunity. Transcriptional analysis revealed that besides IL-15, IL-32 was the only other cytokine expressed by human Langerhans cells. IL-32 is a human cytokine that exists in four main isoforms. Currently, little is known about the regulation and function of the various IL-32 isoforms. In this study, we found that IL-15 is a potent inducer of IL-32α in DCs. Because IL-15 promotes NK cell activation, we investigated the interplay between IL-32 and IL-15 and their role in NK cell activity. We show that IL-32α acts on NK cells to inhibit IL-15-mediated STAT5 phosphorylation and to suppress their IL-15-induced effector molecule expression and cytolytic capacity. IL-32α also acted on DCs by downregulating IL-15-induced IL-18 production, an important cytokine in NK cell activity. Blocking IL-32α during DC:NK cell coculture enhanced NK cell effector molecule expression as well as their cytolytic capacity. Taken together, our findings suggest a feedback inhibition of IL-15-mediated NK cell activity by IL-32α.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28701509      PMCID: PMC5544929          DOI: 10.4049/jimmunol.1601477

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

Review 1.  Langerhans cells in innate defense against pathogens.

Authors:  Marein A W P de Jong; Teunis B H Geijtenbeek
Journal:  Trends Immunol       Date:  2010-10-26       Impact factor: 16.687

2.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.

Authors:  C Caux; C Massacrier; B Vanbervliet; B Dubois; I Durand; M Cella; A Lanzavecchia; J Banchereau
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

3.  STAT5 Loss Awakens the Dark Force in Natural Killer Cells.

Authors:  Jing Ni; Adelheid Cerwenka
Journal:  Cancer Discov       Date:  2016-04       Impact factor: 39.397

4.  IL-32 promotes angiogenesis.

Authors:  Claudia A Nold-Petry; Ina Rudloff; Yvonne Baumer; Menotti Ruvo; Daniela Marasco; Paolo Botti; Laszlo Farkas; Steven X Cho; Jarod A Zepp; Tania Azam; Hannah Dinkel; Brent E Palmer; William A Boisvert; Carlyne D Cool; Laima Taraseviciene-Stewart; Bas Heinhuis; Leo A B Joosten; Charles A Dinarello; Norbert F Voelkel; Marcel F Nold
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

5.  The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages.

Authors:  Amy Gillgrass; Navkiran Gill; Artem Babian; Ali A Ashkar
Journal:  J Immunol       Date:  2014-10-29       Impact factor: 5.422

6.  TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.

Authors:  Courtney A Crane; Seunggu J Han; Jeffery J Barry; Brian J Ahn; Lewis L Lanier; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2009-11-05       Impact factor: 12.300

7.  Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.

Authors:  Katia Monteleone; Pierluigi Di Maio; Giulia Cacciotti; Francesca Falasca; Maurizio Fraulo; Mario Falciano; Ivano Mezzaroma; Gabriella D'Ettorre; Ombretta Turriziani; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2014-02-20       Impact factor: 3.402

8.  Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.

Authors:  Loredana Cifaldi; Giusi Prencipe; Ivan Caiello; Claudia Bracaglia; Franco Locatelli; Fabrizio De Benedetti; Raffaele Strippoli
Journal:  Arthritis Rheumatol       Date:  2015-11       Impact factor: 10.995

9.  Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer.

Authors:  Nasser Ghaly Yousif; Fadhil G Al-Amran; Najah Hadi; Jillen Lee; Jonthan Adrienne
Journal:  Cytokine       Date:  2012-10-26       Impact factor: 3.861

Review 10.  IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction.

Authors:  Bana Jabri; Valérie Abadie
Journal:  Nat Rev Immunol       Date:  2015-11-16       Impact factor: 53.106

View more
  7 in total

Review 1.  Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.

Authors:  Benedikt Jacobs; Veronika Gebel; Lukas Heger; Victoria Grèze; Hansjörg Schild; Diana Dudziak; Evelyn Ullrich
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 2.  The Biology and Role of Interleukin-32 in Tuberculosis.

Authors:  Wu Li; Wanyan Deng; Jianping Xie
Journal:  J Immunol Res       Date:  2018-10-22       Impact factor: 4.818

3.  Human genes influence the interaction between Streptococcus mutans and host caries susceptibility: a genome-wide association study in children with primary dentition.

Authors:  Ying Meng; Tongtong Wu; Ronald Billings; Dorota T Kopycka-Kedzierawski; Jin Xiao
Journal:  Int J Oral Sci       Date:  2019-05-30       Impact factor: 6.344

4.  Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function.

Authors:  Clara Degos; Mellie Heinemann; Julien Barrou; Nicolas Boucherit; Eric Lambaudie; Ariel Savina; Laurent Gorvel; Daniel Olive
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

5.  Interleukin 32 expression in human melanoma.

Authors:  Helicia Paz; Jennifer Tsoi; Anusha Kalbasi; Catherine S Grasso; William H McBride; Dörthe Schaue; Lisa H Butterfield; Deena M Maurer; Antoni Ribas; Thomas G Graeber; James S Economou
Journal:  J Transl Med       Date:  2019-04-05       Impact factor: 5.531

6.  Genetic variation in Interleukin-32 influence the immune response against New World Leishmania species and susceptibility to American Tegumentary Leishmaniasis.

Authors:  Jéssica Cristina Dos Santos; Valéria Bernadete Leite Quixabeira; Muriel Vilela Teodoro Silva; Michelle S M A Damen; Kiki Schraa; Martin Jaeger; Marije Oosting; Samuel T Keating; Miriam Leandro Dorta; Sebastião Alves Pinto; Fernanda Bugalho Duarte; Ledice Inácia de Araújo Pereira; Mihai G Netea; Fátima Ribeiro-Dias; Leo A B Joosten
Journal:  PLoS Negl Trop Dis       Date:  2020-02-05

Review 7.  Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.

Authors:  Silvia Gaggero; Kristina Witt; Mattias Carlsten; Suman Mitra
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.